What happens when a sex therapist visits a women-only Parkinson’s support group? A frank exchange about “redefining sexuality”, recalls Sharon Krischer AKA ‘Twitchy Woman’
Recently, psychologist and certified sex therapist, Dr Beth Leedham, spoke to our women’s support group about sex. A women-only environment allowed for an honest discussion about issues relating to Parkinson’s and our sexual behaviour.
According to Dr Leedham, most doctors and therapists are not comfortable about talking about it, and their patients are not comfortable talking about it, so no one talks about it.
There is very little research about women with Parkinson’s and sexuality. She started with an old survey, from 1992. The question was: “Over the last 12 months have you…?”
And the results: 43% of women and 31% of men reported having sexual dysfunction. The rate is higher in populations with mental or physical health issues. So this is a very common issue among all adults.
In a study of women with Parkinson’s, the most common difficulty is getting aroused (*87.5%). Parkinson’s affects the autonomic nervous system, and that is the system responsible for arousal. Others include difficulty reaching orgasm (75%) and dyspareunia or painful sex (12.5%).
Some of the causes: motor changes, bladder changes, cognitive changes, differences communicating emotion, sleep disturbance, depression, changes in self-esteem and body image, medication side effects and on and on.
“Most doctors and therapists are not comfortable about talking about it”
Sexuality statistics (Taken from a study in 1992)
43% of women and 31% of men with Parkinson’s reported experiencing sexual dysfunction
87.5% of women with Parkinson’s have difficulty is getting aroused Parkinson’s
75% have difficulty reaching orgasm
12.5% experience dyspareunia or painful intercourse
Was it “meh” for you too?
In addition, the normal issues related to aging can cause problems. Decrease of oestrogen and testosterone with menopause, vaginal tissues become thinner, decrease in lubrication. Men have aging issues too. So sexual dysfunction increases among all men and women as they age. The prevalence of sexual dysfunction among women with Parkinson’s is slightly higher than that of post-menopausal women. So is the problem due to aging or is it due to Parkinson’s?
In many cases changes in long-term relationships because of the condition can cause conflicts for both the person with Parkinson’s and the partner. Sometimes, the partner experiences ‘well-spouse’ stress. ‘Enmeshment’, or unwelcome intimacies (closeness that is too close) can occur after a diagnosis. The well spouse may feel solely responsible for the partner with Parkinson’s.
The number one issue, however, is differences in desire between the two partners. Some of the issues are due to the aging of both partners, some are because of Parkinson’s and some are because of differences in expectations. We forget that we are not 20 years old anymore and that we experience things differently now. It is ok to negotiate and change things. Fix the causes that can be fixed.
Accommodate for aging. Address relationship issues. Take risks and try new things. Look at it as an opportunity to redefine and reclaim sexuality and eroticism.
This article is an edited version of a post that originally appeared on ‘Twitchy Woman’s Adventures with Parkinson’s’ and is re-published with the permission of Sharon Krischer. Read more of her blog here
We talk to the British author about living with Parkinson’s for two decad
4 days ago
Study suggests why neurons die in Parkinson’s disease
Researchers at the University of Córdoba, Spain, have discovered how a certain protein may be linked to death of dopamine-producing neurons associated with Parkinson’s. Using animal models of the condition to conduct their study, the team focused on the protein DJ-1 – whose link to Parkinson’s has previously been established, though its exact function was uncertain. The researchers compared neurons in the brains of mice that possessed the gene expressing DJ-1 with those that did not. The findings revealed that dysfunction or absence of the gene expressing the DJ-1 protein could trigger the ‘cell cycle’ (the process by which cells divide), which should not occur under normal conditions. Because neurons lack the capacity to divide, this causes them die – leading to the onset of symptoms linked with Parkinson’s. It is hoped that uncovering these details about the relationship between DJ-1’s absence and Parkinson’s may lead to the development of…
Researchers have finally identified brain cells linked to Parkinson’s disease
For decades, scientists have known that Parkinson’s is associated with the death of dopamine-producing cells in the brain. Now, researchers from the Broad Institute of MIT and Harvard, US, have discovered the specific subtype of brain cells that die in Parkinson’s disease. Using a technique called single-cell RNA signalling, which enables the individual analysis of cells within a tissue for activity and protein production, researchers identified 10 subtypes of dopamine-producing cells within the donated brains of people who died from causes unrelated to Parkinson’s. The team carried out the same investigation on people who had died with Parkinson’s or a condition with similar symptoms called Lewy body dementia. They discovered that only one subtype of the cells had reduced in number – which suggests many of these cells had died while the people were living. It is hoped that the findings could lead to better understanding of Parkinson’s causes and…
Tiny DBS implant shows potential to advance Parkinson’s disease treatment
In an innovative trial by North Bristol NHS Trust, UK, surgeons have succeeded in implanting a tiny deep brain stimulation (DBS) device into a person’s skull. Their aim? To address symptoms of Parkinson’s. Designed with a tiny battery system that is inserted into the skull, the DBS device delivers electric impulses to targeted areas of the brain through electric probes. In doing so, it works to address abnormal brain cell activity associated with Parkinson’s – and may help to ease symptoms. One of around 25 patients selected for the year-long trial has described the device’s impact as “amazing”. Commenting on the results of the trial so far, consultant neurologist Dr Alan Whone of North Bristol NHS Trust said: “We are hopeful that if these findings hold up, we will have a significant technical advance by which to improve Parkinson’s care across the world.”